Cargando…
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
PURPOSE/OBJECTIVE(S): To analyze the long term efficacy and safety of an ultra-hypofractionated (UHF) radiation therapy prostate treatment regimen with HDR brachytherapy boost (BB) and compare it to moderate-hypofractionated regimens (MHF). MATERIALS/METHODS: In this single arm, prospective monocent...
Autores principales: | Beaudry, M.M., Carignan, D., Foster, W., Lavallee, M.C., Aubin, S., Lacroix, F., Poulin, E., Lachance, B., Després, P., Beaulieu, L., Vigneault, E., Martin, A.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974413/ https://www.ncbi.nlm.nih.gov/pubmed/36875870 http://dx.doi.org/10.1016/j.ctro.2023.100593 |
Ejemplares similares
-
Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy
por: Vigneault, Eric, et al.
Publicado: (2016) -
Hypofractionated external beam radiation therapy in combination with HDR boost for localized prostate cancer: patient reported quality of life outcomes
por: Morgan, Tiffany M, et al.
Publicado: (2018) -
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022) -
Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021) -
Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)